BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17922029)

  • 1. Complex patterns of ETS gene alteration arise during cancer development in the human prostate.
    Clark J; Attard G; Jhavar S; Flohr P; Reid A; De-Bono J; Eeles R; Scardino P; Cuzick J; Fisher G; Parker MD; Foster CS; Berney D; Kovacs G; Cooper CS
    Oncogene; 2008 Mar; 27(14):1993-2003. PubMed ID: 17922029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
    Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N
    Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].
    Allina DO; Kekeeva TV; Moskvina LV; Shikeeva AA; Andreeva YY; Zavalishina LE; Frank GA
    Arkh Patol; 2015; 77(5):36-42. PubMed ID: 26978019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.
    Scheble VJ; Braun M; Beroukhim R; Mermel CH; Ruiz C; Wilbertz T; Stiedl AC; Petersen K; Reischl M; Kuefer R; Schilling D; Fend F; Kristiansen G; Meyerson M; Rubin MA; Bubendorf L; Perner S
    Mod Pathol; 2010 Aug; 23(8):1061-7. PubMed ID: 20473283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer.
    Shrestha E; Coulter JB; Guzman W; Ozbek B; Hess MM; Mummert L; Ernst SE; Maynard JP; Meeker AK; Heaphy CM; Haffner MC; De Marzo AM; Sfanos KS
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34341114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.
    Morais CL; Guedes LB; Hicks J; Baras AS; De Marzo AM; Lotan TL
    Hum Pathol; 2016 Sep; 55():117-25. PubMed ID: 27189342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
    Yang Y; Blee AM; Wang D; An J; Pan Y; Yan Y; Ma T; He Y; Dugdale J; Hou X; Zhang J; Weroha SJ; Zhu WG; Wang YA; DePinho RA; Xu W; Huang H
    Cancer Res; 2017 Dec; 77(23):6524-6537. PubMed ID: 28986382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.
    Torres A; Alshalalfa M; Tomlins SA; Erho N; Gibb EA; Chelliserry J; Lim L; Lam LLC; Faraj SF; Bezerra SM; Davicioni E; Yousefi K; Ross AE; Netto GJ; Schaeffer EM; Lotan TL
    J Mol Diagn; 2017 May; 19(3):475-484. PubMed ID: 28341589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
    Alhamar M; Tudor Vladislav I; Smith SC; Gao Y; Cheng L; Favazza LA; Alani AM; Ittmann MM; Riddle ND; Whiteley LJ; Gupta NS; Carskadon S; Gomez-Gelvez JC; Chitale DA; Palanisamy N; Hes O; Trpkov K; Williamson SR
    Histopathology; 2020 Dec; 77(6):890-899. PubMed ID: 32639612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of High-Throughput Screening Assays for Inhibitors of ETS Transcription Factors.
    Currie SL; Warner SL; Vankayalapati H; Liu X; Sharma S; Bearss DJ; Graves BJ
    SLAS Discov; 2019 Jan; 24(1):77-85. PubMed ID: 30204534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization.
    Dedigama-Arachchige P; Carskadon S; Li J; Loveless I; Alhamar M; Peabody JO; Stricker H; Chitale DA; Rogers CG; Menon M; Gupta NS; Bismar TA; Williamson SR; Palanisamy N
    Mod Pathol; 2020 Sep; 33(9):1791-1801. PubMed ID: 32238875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS factors in prostate cancer.
    Qian C; Li D; Chen Y
    Cancer Lett; 2022 Apr; 530():181-189. PubMed ID: 35033589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis.
    Kidd SG; Bogaard M; Carm KT; Bakken AC; Maltau AMV; Løvf M; Lothe RA; Axcrona K; Axcrona U; Skotheim RI
    Mol Oncol; 2022 Aug; 16(15):2810-2822. PubMed ID: 35574900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation.
    Lorenzoni M; De Felice D; Beccaceci G; Di Donato G; Foletto V; Genovesi S; Bertossi A; Cambuli F; Lorenzin F; Savino A; Avalle L; Cimadamore A; Montironi R; Weber V; Carbone FG; Barbareschi M; Demichelis F; Romanel A; Poli V; Del Sal G; Julio MK; Gaspari M; Alaimo A; Lunardi A
    Cancer Lett; 2022 May; 534():215612. PubMed ID: 35259458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genomics of Prostate Cancer: emerging understanding with technologic advances.
    Rubin MA; Demichelis F
    Mod Pathol; 2018 Jan; 31(S1):S1-11. PubMed ID: 29297493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens.
    Schafer C; Young D; Singh H; Jayakrishnan R; Banerjee S; Song Y; Dobi A; Petrovics G; Srivastava S; Srivastava S; Sesterhenn IA; Chesnut GT; Tan SH
    J Immunol Methods; 2023 Jul; 518():113493. PubMed ID: 37196930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.
    Hemani R; Patel I; Inamdar N; Campanelli G; Donovan V; Kumar A; Levenson AS
    Cancer Prev Res (Phila); 2022 Feb; 15(2):87-100. PubMed ID: 34675064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfall regarding expression of ETS-related gene (ERG) in fibrohistiocytic neoplasms.
    Friedman BJ
    J Cutan Pathol; 2021 Jul; 48(7):1003-1004. PubMed ID: 33837979
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychiatrie en sociaal domein: 'living apart together' of 'living together apart'?].
    Beekman ATF
    Tijdschr Psychiatr; 2022; 64(6):346-347. PubMed ID: 35748144
    [No Abstract]   [Full Text] [Related]  

  • 20. Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.
    Taplin ME; Montgomery B; Logothetis CJ; Bubley GJ; Richie JP; Dalkin BL; Sanda MG; Davis JW; Loda M; True LD; Troncoso P; Ye H; Lis RT; Marck BT; Matsumoto AM; Balk SP; Mostaghel EA; Penning TM; Nelson PS; Xie W; Jiang Z; Haqq CM; Tamae D; Tran N; Peng W; Kheoh T; Molina A; Kantoff PW
    J Clin Oncol; 2014 Nov; 32(33):3705-15. PubMed ID: 25311217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.